KIT and psoriasis: KIT mRNA expression level in lesional skin of psoriasis patients was 4.6-fold lower (p < 0.001; Figure 3j) and in psoriasis non-involved skin it was 4.2-fold lower (p < 0.001; Figure 3j) than in the skin of healthy control subjects.